natgillin/translations-raw huggingface dataset:
Before beginning treatment or resuming treatment after a recovery period Complete blood count with differential blood count and platelets, liver enzymes, bilirubin, serum albumin, chest X-ray and renal function tests.
Potrebno je napraviti kompletnu krvnu sliku s diferencijalnom krvnom slikom i trombocitima, pretrage jetrenih enzima, bilirubina, serumskog albumina, rendgensku snimku prsnog koša i testove funkcije bubrega.
• Information on treatment with Jylamvo, administration and posology.
• Podatke o liječenju lijekom Jylamvo, njegovoj primjeni i doziranju.
The oral solution contains 2 mg of methotrexate in each ml of solution; the scaling of the dosing syringe is in ml and not mg; care should be taken that the correct dosing volume is prescribed.
4.4 Posebna upozorenja i mjere opreza pri uporabi Oralna otopina sadrži 2 mg metotreksata u jednom ml otopine; mjerne oznake na štrcaljki za doziranje navedene su u ml a ne mg; potrebno je paziti da se propiše ispravan volumen doze.
Malignant lymphomas
Zloćudni limfomi
Treatment of rheumatoid arthritis, severe juvenile idiopathic arthritis, severe psoriasis and severe psoriatic arthritis with Jylamvo is a long-term treatment.
Liječenje reumatoidnog artritisa, teškog juvenilnog idiopatskog artritisa, teške psorijaze i teškog psorijatičnog artritisa lijekom Jylamvo dugotrajno je liječenje.
If you do become pregnant during treatment, you should be offered advice regarding the risk of harmful effects on the child through treatment.
Vas se savjetovati o rizicima štetnog učinka liječenja na dijete.
Muscular asthenia or paraesthesia of the extremities, Taste changes (metallic taste), Irritation,
mišićna astenija ili parestezija udova, promjene osjeta encefalopatija/ leukoencefalopati ja okusa (metalni okus) iritacija, disartrija,
For protection, you should wear disposable gloves when handling Jylamvo.
Kada rukujete lijekom Jylamvo, nosite jednokratne rukavice zbog zaštite.
Symptoms of overdose are e.g. sore throat, fever, mouth ulcers, diarrhoea, vomiting, skin rashes, bleeding or unusual weakness.
Simptomi predoziranja su npr. grlobolja, vrućica, vrijedovi u ustima, proljev, povraćanje, kožni osipi, krvarenje ili neuobičajena slabost.
Psoriatic lesions can worsen during UV radiation and co-administration of methotrexate.
Psorijatične lezije mogu se pogoršati pri izlaganju ultraljubičastom zračenju i istodobnoj primjeni metotreksata.
Taking Jylamvo incorrectly can result in severe side effects and even death.
Nepravilna primjena lijeka Jylamvo može za posljedicu imati teške nuspojave i čak smrtni ishod.
Severe, occasionally fatal, dermatologic reactions, including toxic epidermal necrolysis (Lyell's syndrome) or Stevens-Johnson syndrome have been reported after single or multiple doses of methotrexate.
(Lyellov sindrom) ili Stevens-Johnsonov sindrom, zabilježene su nakon jedne ili više doza metotreksata.
Nocardiosis, Histoplasma and cryptococcus mycosis, Disseminated herpes simplex
herpes zoster sepsa, infekcije izazvane citomegalovirusom nokardioza, histoplazmoza i kriptokokoza, diseminirani herpes simpleks
Prior to initiating therapy, women of childbearing potential must be informed of the risk of malformations associated with methotrexate and any existing pregnancy must be excluded with certainty by taking appropriate measures, e.g. a pregnancy test. During treatment pregnancy tests should be repeated as clinically required (e.g. after any gap of contraception).
Prije započinjanja terapije žene reproduktivne dobi moraju biti upoznate s rizicima od malformacija povezanih s primjenom metotreksata te se provođenjem odgovarajućih mjera, npr. testom na trudnoću,
This evaluation should differentiate between patients with no risk factors and patients with risk factors, such as excessive prior alcohol consumption, persistent elevation of liver enzymes, history of liver disease, family history of a hereditary liver disease, diabetes mellitus, obesity and history of significant exposure to hepatotoxic medicinal product or chemicals, as well as prolonged methotrexate treatment or a cumulative total dose of 1.5 g or more.
Ova procjena trebala bi razlikovati bolesnike u kojih ne postoje čimbenici rizika od onih u kojih ti rizici postoje, kao što je primjerice prethodna prekomjerna konzumacija alkohola, trajno povišeni jetreni enzimi, bolest jetre u anamnezi, nasljedna bolest jetre u obiteljskoj anamnezi,
Confirm that the dose in the syringe is correct.
Provjerite je li u štrcaljki točna količina doze.
Treatment of active rheumatoid arthritis, severe JIA, severe psoriasis and severe psoriatic arthritis represents a long-term treatment.
Liječenje aktivnog reumatoidnog artritisa, teškog juvenilnog idiopatskog artritisa, teške psorijaze i teškog psorijatičnog artritisa predstavlja dugotrajno liječenje.
Oral solution 60 ml bottle Bottle adaptor 10 ml dosing syringe
Oralna otopina boca od 60 ml nastavak za bocu štrcaljka za doziranje od 10 ml
The other ingredients are: macrogol 400, glycerol, orange flavour, sucralose, ethyl parahydroxybenzoate (E214), sodium methyl parahydroxybenzoate (E219), citric acid, tri-sodium citrate, purified water.
Drugi sastojci su: makrogol 400, glicerol, okus naranče, sukraloza, etilparahidroksibenzoat (E214),
Fever,
− vrućica.
− loss of appetite, feeling sick (nausea), vomiting, abdominal pain, indigestion, inflammation and ulcers of the mouth and throat
− gubitak apetita, mučnina, povraćanje, bol u trbuhu, probavne smetnje, upala i vrijedove u ustima i grlu
− lymphoproliferative disorders (excessive growth of white blood cells)
− limfoproliferativni poremećaji (prekomjerno stvaranje bijelih krvnih stanica) − nesanica
Jylamvo is for oral use only.
Jylamvo je samo za peroralnu primjenu.
Jylamvo contains ethyl parahydroxybenzoate and sodium methyl parahydroxybenzoate
Jylamvo sadrži etilparahidroksibenzoat i natrijev metilparahidroksibenzoat
Very rare (may affect up to 1 in 10,000 people):
Vrlo rijetke (mogu se pojaviti u do 1 na 10 000 osoba):
− liver failure
− zatajenje jetre
Other frequently (common) occurring adverse reactions are leukopenia, anaemia, thrombopenia, headache, tiredness, drowsiness, pneumonia, interstitial alveolitis/pneumonitis often associated with eosinophilia, oral ulcers, diarrhoea, exanthema, erythema and pruritus.
anemija, trombopenija, glavobolja, umor, omamljenost, pneumonija, intersticijski alveolitis/pneumonitis često povezan s eozinofilijom, oralnim ulkusima, proljevom, egzantemom,
Eosinophilia, Neutropenia, Lymphadenopathy
eozinofilija, neutropenija, limfadenopatija hemoragije
− severe fatigue.
− težak umor.
Jylamvo 2 mg/ml oral solution methotrexate
Jylamvo 2 mg/ml oralna otopina metotreksat
− accumulation of fluid in the lung, lung infections
− nakupljanje tekućine u plućima, infekcije pluća
Patients should be instructed on the importance of adhering to the once-weekly intakes.
Bolesnike se mora uputiti na važnost pridržavanja rasporeda uzimanja lijeka jednom tjedno.
− nausea, vomiting, abdominal discomfort or severe diarrhoea
− mučnina, povraćanje, nelagoda u trbuhu ili težak proljev
− bone damage in the jaw (secondary to excessive growth of white blood cells).
− krvarenje iz pluća* − oštećenje kosti čeljusti (uslijed prekomjernog stvaranje bijelih krvnih stanica).
− breathing problems (these include a general feeling of illness, dry, irritating cough, shortness of breath, difficulty in breathing, chest pain or fever)
− tegobe s disanjem (one uključuju opći osjećaj bolesti, suh, nadražujući kašalj, nedostatak zraka,
However, an increased monitoring frequency is indicated if the dosage is increased.
Međutim, ako se poveća doza, indicirano je učestalije praćenje.
− viral, fungal or bacterial systemic infections,
− virusne, gljivične ili bakterijske sistemske infekcije − ozbiljan poremećaj koštane srži (anemija), otečene žlijezde
Low-dose methotrexate is used in the maintenance treatment of ALL in children aged 3 years and over, adolescents and adults within complex protocols in combination with other cytostatic medicinal products.
adolescenata i odraslih, metotreksat se primjenjuje u niskoj dozi u kombinaciji s drugim citostaticima u okviru složenih protokola.
− fingernail infections, detachment of the nail from the nail bed, boils, widening of small blood vessels, damage to the blood vessels of the skin, allergic inflammation of blood vessels
− infekcije noktiju, odvajanje noktiju od ležišta, čirevi na koži, proširenje malih krvnih žila,
Male Fertility
Muška plodnost
Dermatitis and sunburn
Dermatitis i opekline od sunca
In the event of (prior) treatment with medicinal products that can have adverse reactions on bone marrow (e.g. sulphonamides, trimethoprim/sulphamethoxazole, chloramphenicol, pyrimethamine), the possibility of haematopoietic disorders must be considered.
sulfonamidi, trimetoprim/sulfametoksazol, kloramfenikol, pirimetamin), mora se uzeti u obzir mogućnost hematopoetskih poremećaja.
− fever, sore throat, flu-like symptoms
− vrućica, grlobolja, simptomi nalik gripi
− skin rash, skin redness and itching.
− proljev − kožni osip, crvenilo kože i svrbež.
Following the occurrence of haematemesis, black-coloured stools or blood in the stools, treatment must be discontinued.
Liječenje se mora prekinuti nakon pojave hematemeze, stolice crne boje ili krvi u stolici.
Depression Mood swings Insomnia
Psihijatrijski poremećaji depresija promjene raspoloženja nesanica
If you suffer from diarrhoea please speak to your doctor.
Ako imate proljev, obratite se liječniku.
Ethyl parahydroxybenzoate (E214) Sodium methyl parahydroxybenzoate (E219) Citric acid monohydrate
6.1 Popis pomoćnih tvari makrogol 400 glicerol okus naranče sukraloza etilparahidroksibenzoat (E214) natrijev metilparahidroksibenzoat (E219) citratna kiselina hidrat trinatrijev citrat pročišćena voda
The prescriber should make sure patients understand that Jylamvo (methotrexate) should only be taken once a week.
Liječnik koji propisuje lijek mora provjeriti da bolesnici razumiju da se lijek Jylamvo (metotreksat)
Metabolism and nutrition disorders
Poremećaji metabolizma i prehrane šećerna bolest
Your doctor will tell you what dose you should take for your condition and when you should take the dose.
Doza u akutnoj limfoblastičnoj leukemiji (ALL) Liječnik će Vam reći koju dozu morate uzimati za svoje stanje te kada je morate uzeti.
− loss of sex drive, erection problems, vaginal discharge, infertility, enlargement of the breasts in men (gynaecomastia) − fever.
− protein u mokraći − gubitak spolnog nagona, teškoće s erekcijom, iscjedak iz rodnice, neplodnost, povećanje dojki u muškaraca (ginekomastija)
Osteonecrosis of jaw (secondary to lymphoprolifer -ative disorders)
Osteonekroza čeljusti (uslijed limfoproliferativn
− mood swings
− promjene raspoloženja
− kidney disease, inflammation or ulcers of the bladder (possibly also with blood in the urine),
− bolest bubrega, upala ili ranice mokraćnog mjehura (moguća i krv u mokraći), bolno mokrenje
− inflammation of the lungs (pneumonia) with dry cough, shortness of breath and fever
− glavobolja, umor, ošamućenost − upala pluća (pneumonija) sa suhim kašljem, nedostatkom zraka i vrućicom
5.3 Preclinical safety data
5.3 Neklinički podaci o sigurnosti primjene Kronična toksičnost
− lung damage
− oštećenje pluća
Take the medicine pack with you when you visit your doctor or the hospital.
Kada odlazite liječniku ili u bolnicu, sa sobom ponesite pakiranje lijeka.
Allergic reactions, Anaphylactic shock,
Poremećaji imunološkog sustava alergijske reakcije,
Cerebral oedema, Acute aseptic meningitis with meningism (paralysis, vomiting), Lethargy,
akutni aseptički meningitis s meningizmom (paraliza,
Put on disposable gloves before handling.
Prije rukovanja navucite jednokratne rukavice.
Particularly in the case of orthopaedic surgery where the risk of infection is high, combination therapy with methotrexate and immunomodulatory medicinal products must be used with caution.
Osobito u slučaju ortopedskih kirurških zahvata pri kojima postoji visoki rizik od infekcije,
Data from a randomised trial in patients with juvenile rheumatoid arthritis (aged 2.8 to 15.1 years) indicated greater oral bioavailability of methotrexate in the fasting state.
Podaci iz randomiziranog ispitivanja u bolesnika s juvenilnim reumatoidnim artritisom (u dobi od 2,8
Especially strict monitoring of the patient is indicated following prior radiotherapy (especially of the pelvis), functional impairment of the haematopoietic system (e.g., following prior radio- or chemotherapy), impaired general condition as well as advanced age and in very young children.
Posebno strogo praćenje bolesnika indicirano je nakon prethodne radioterapije (osobito zdjelice),
− low blood pressure, blood clots
− nizak krvni tlak, krvni ugrušci − upala krajnika, prekid disanja, astma
shingles [herpes zoster]) as they may flare up - if you have ever had any liver or kidney disease - if you have problems with your lung function - if you are particularly overweight - if you have an abnormal build-up of fluid in the abdomen (ascites) or around the lungs (pleural effusions) - if you are dried out (dehydrated) or suffer from conditions that result in dehydration (vomiting,
− ako imate abnormalno nakupljanje tekućina u području trbuha (ascites) ili oko pluća (pleuralna efuzija) − ako Vam nedostaje vode u tijelu (dehidrirani ste) ili bolujete od stanja koja za posljedicu imaju dehidraciju (povraćanje, proljev, zatvor, upala sluznice usta).
Methotrexate is a powerful human teratogen, with an increased risk of spontaneous abortions, intrauterine growth restriction and congenital malformations in case of exposure during pregnancy.
zastoja intrauterinog rasta i urođenih malformacija u slučaju izlaganja tijekom trudnoće.
− diarrhoea
− sedative
The occurrence and severity of adverse reactions depend on dosage level and frequency of administration of methotrexate.
Pojava i težina nuspojava ovise o dozi i učestalosti primjene metotreksata.
− inflammation of the pancreas, inflammation of the digestive tract, bloody stools, inflamed gums,
− upala gušterače, upala probavnog sustava, krvave stolice, upaljene desni, probavne smetnje
For arthritis and psoriasis take only once a week on ………….
Za liječenje artritisa i psorijaze uzimati samo jednom tjedno u ………………(navesti puni naziv dana u tjednu kada se lijek uzima).
Telangiectasis, Hidradenitis
akutna paronihija, furunkuloza, teleangiektazija, hidradenitis
Thromboembolic reactions (including arterial and cerebral thrombosis, thrombophlebitis, deep leg vein thrombosis, retinal vein thrombosis, pulmonary embolism), Hypotension
(uključujući arterijsku i cerbralnu trombozu, tromboflebitis, trombozu dubokih vena nogu, trombozu vena mrežnice,
Pruritus vasculitis, herpetiform skin eruptions, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome), Increased rheumatic nodules,
toksična epidermalna nekroliza (Lyellov sindrom), povećanje broja reumatoidnih čvorića,
How to store Jylamvo
Moguće nuspojave Kako čuvati Jylamvo
The dose should be adjusted as follows for patients with rheumatoid arthritis, juvenile arthritis, psoriasis and psoriatic arthritis.
U bolesnika s reumatoidnim artritisom, juvenilnim artritisom, psorijazom i psorijatičnim artritisom dozu treba prilagoditi kako je prikazano u nastavku.
Men should not donate semen during therapy or for 6 months following discontinuation of methotrexate.
Muškarci ne smiju donirati sjeme tijekom liječenja i tijekom
Pulmonary fibrosis
AUC metabolita
Petechiae, Bruising, Erythema multiforme, Cutaneous erythematous eruptions, Lesions of psoriasis may worsen with concomitant UV therapy, Radiation dermatitis and sunburn may be “recalled”
psorijatične lezije mogu se pogoršati uz istodobnu UV terapiju, radijacijski dermatitis i opekline od sunca mogu se pojaviti kao “odzivna reakcija”
Push the tip of the dosing syringe into the hole in the adaptor.
Vrh štrcaljke za doziranje gurnite u otvor nastavka za bočicu.
Megaloblastic anaemia
aplastična anemija,
However, a risk cannot be completely excluded and there is no information regarding higher methotrexate doses.
Međutim, rizik se ne može u potpunosti isključiti.
Concomitant therapy with medicinal products that can cause folic acid deficiency (e.g. sulphonamides, trimethoprim/sulphamethoxazole) can result in increased methotrexate toxicity.
Istodobna terapija lijekovima koji mogu prouzročiti nedostatak folatne kiseline (npr. sulfonamidi,
• Concurrent vaccination with live vaccines
• istodobno cijepljenje živim cjepivima.
Dose reduction should be considered in elderly patients (65 years and over) due to reduced liver and kidney function as well as low folic acid reserves which occur with increased age.
Zbog slabije funkcije jetre i bubrega te niskih rezervi folatne kiseline koje se javljaju s uznapredovalom dobi, u starijih bolesnika (65 godina i stariji) treba razmotriti smanjenje doze.
Methotrexate should be administered only with the greatest caution, if at all, in patients with significant existing or previous liver disease, especially if due to alcohol.
U bolesnika sa značajnom postojećom ili prethodnom bolešću jetre, a osobito ako je prouzročena alkoholom, metotreksat, ako uopće, treba primjenjivati samo s najvećim oprezom.
Pain,
zimica,
Doses exceeding 20 mg (10 ml)/week can be associated with a substantial increase in toxicity,
Doze veće od 20 mg (10 ml) tjedno mogu se povezati sa značajnim povećanjem toksičnosti, osobito s depresijom koštane srži.
Dosage in adult rheumatoid arthritis: The usual initial dose is 7.5 mg (3.75 ml), once a week.
Uobičajena početna doza je 7,5 mg (3,75 ml) jednom tjedno.
Pericarditis, Pericardial effusion, Pericardial tamponade
Srčani poremećaji perikarditis, perikardijalna efuzija, perikardijalna tamponada
If you had skin problems after radiotherapy (radiation dermatitis) or sunburn, these reactions can recur after methotrexate therapy (recall reaction).
Ako imate problema s kožom nakon terapije zračenjem (radijacijski dermatitis) ili opekline od sunca,
This oral solution contains 2 mg methotrexate in 1 ml solution and the scaling of the dosing syringe is in ml and not mg.
Upozorenja i mjere opreza Važno upozorenje o dozi lijeka Jylamvo (metotreksata): Ova oralna otopina sadrži 2 mg metotreksata u 1 ml otopine, a mjerne oznake na dozirnoj štrcaljki odnose se na ml, a ne na mg.
You and your partner should avoid having a baby if you are being given methotrexate at the time and for at least 6 months after the end of your treatment with methotrexate.
Ako primate metotreksat, Vi i partner/partnerica morate izbjegavati trudnoću tijekom liječenja i još najmanje 6 mjeseci nakon završetka liječenja metotreksatom.
Aplastic anaemia, Lymphoproliferative disorder2,
limfoproliferativni poremećaj2,
Closer monitoring of liver enzymes should be undertaken in patients taking other hepatotoxic medicinal products concomitantly (e.g. leflunomide).
U bolesnika koji istodobno uzimaju druge hepatotoksične lijekove (npr. leflunomid), potrebno je pažljivije praćenje jetrenih enzima.
Oral solution.
Citotoksično.
− inflammation and ulcers of the vagina.
− upala i ranice u rodnici.
Photosensitivity, Increased skin pigmentation, Hair loss, Impaired wound healing,
povećana pigmentacija kože, gubitak kose, narušeno cijeljenje rana, urtikarija nastanak modrica, multiformni eritem, kožne eritematozne erupcije,
(include weekday of intake in full).
(uključujući redovne laboratorijske testove).
Take Jylamvo only once a week for the treatment of rheumatic or skin diseases (RA, JIA and psoriasis or psoriatic arthritis).
Za liječenje reumatskih ili kožnih bolesti (reumatoidni artritis, juvenilni idiopatski artritis i psorijaza ili psorijatični artritis), uzmite Jylamvo samo jedanput tjedno.
Proteinuria
hematemeza
− bone fractures
− lomovi kostiju
− mouth ulcers
I PSORIJAZE.
Jylamvo is a medicine that: - suppresses the growth of certain cells in the body that multiply rapidly (an anticancer medicine) - reduces unwanted reactions by the body's own defense mechanisms (an immunosuppressive agent) - has an anti-inflammatory effect
− smanjuje neželjene reakcije obrambenog sustava tijela (imunosupresivni lijek)
Vaginal
Jylamvo.
Dose in rheumatic and skin diseases (RA, JIA and psoriasis or psoriatic arthritis)
Doza u reumatskim i kožnim bolestima (reumatoidni artritis, juvenilni idiopatski artritis i psorijaza ili psorijatični artritis) Jylamvo uzimajte samo jedanput tjedno.
Immunosuppression, Allergic vasculitis (severe toxic symptom), Hypogammaglobulinaemia
imunosupresija, alergijski vaskulitis
Diabetes mellitus
− šećerna bolest
Neoplasms benign, malignant and unspecified (including cysts and polyps)
Dobroćudne, zloćudne i nespecificiran e novotvorine
Certain brain disorders (encephalopathy/leukoencephalopathy) have been reported in cancer patients receiving methotrexate.
U bolesnika s rakom koji primaju metotreksat, zabilježeni su neki poremećaji mozga
Erythema, Exanthema,
eritemom i pruritusom.
Highly proliferating tissue such as malignant cells, bone marrow, foetal cells, skin epithelium and mucosa is generally more sensitive to this effect of methotrexate.
Na taj učinak metotreksata uglavnom su osjetljivija tkiva koja brzo proliferiraju kao što su zloćudne stanice, koštana srž, fetalne stanice, kožni epitel i sluznica.
Nephropathy Inflammation and ulceration of urinary bladder (possibly with haematuria), Dysuria
Poremećaji bubrega i mokraćnog sustava nefropatija, upala i ulceracija mokraćnog mjehura (moguće s hematurijom), dizurija zatajenje bubrega, oligurija, anurija, azotemija proteinurija
Side effects affecting the central nervous system such as tiredness or dizziness can occur during treatment with Jylamvo.
Tijekom liječenja lijekom Jylamvo mogu nastati nuspojave koje zahvaćaju središnji živčani sustav, kao što su umor ili omaglica.
It is particularly important to tell your doctor if you are using the following medicines: - other medicines for rheumatoid arthritis or psoriasis, such as leflunomide, azathioprine (also used to prevent rejection after an organ transplant), sulfasalazine (also used for ulcerative colitis) - ciclosporin (for supressing the immune system) - non-steroidal anti-inflammatory drugs or salicylates (medicines against pain and/or inflammation such as acetylsalicylic acid, diclofenac and ibuprofen or pyrazole) - live vaccines
− nesteroidne protuupalne lijekove ili salicilate (lijekove protiv bolova i/ili upale kao što su acetilsalicilatna kiselina, diklofenak i ibuprofen ili pirazol)
Oral use
PRIMJENU
Hepatic impairment
− živa cjepiva
If methotrexate comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water.
treba ga odmah temeljito oprati sapunom i vodom.
This summary was last updated in 11-2016.
Sažetak je posljednji put ažuriran: 11. 2016.
The medicine is available as tablets (15, 30 and 45 mg) and the recommended starting dose is 15 or 30 mg once a day.
Lijek je dostupan u obliku tableta (15, 30 i 45 mg), a preporučena početna doza je 15 ili 30 mg jedanput dnevno.
This means that Pioglitazone Accord is similar to a ‘reference medicine' already authorised in the European Union (EU) called Actos.
To znači da je Pioglitazone Accord sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Actos.
The full EPAR for Pioglitazone Accord can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Cjelovito europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Pioglitazone Accord nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Pioglitazone Accord pioglitazone
Pioglitazone Accord pioglitazon
As a consequence, the blood glucose levels are reduced and this helps to control type 2 diabetes.
Posljedica toga je smanjenje razine glukoze u krvi, što pomaže pri kontroli dijabetesa tipa 2.
Pioglitazone Accord is used to treat type 2 diabetes in adults (aged 18 years or over), particularly those who are overweight.
Lijek Pioglitazone Accord primjenjuje se za liječenje dijabetesa tipa 2 u odraslih osoba (u dobi od 18 godina i starijih), osobito u onih prekomjerne tjelesne težine.